Vazobral, tablets, 30 pcs.
€35.62 €29.69
Combination drug.
a-Dihydroergocriptine is a dihydrogenated derivative of ergot alkaloid, blocks a1- and a2-adrenoreceptors. It has dopaminergic and serotoninergic effects, reduces platelet and erythrocyte aggregation, decreases vascular wall permeability, increases the number of functioning capillaries, improves blood circulation and metabolic processes in the brain, increases resistance of brain tissue to hypoxia.
Indications
Headache, Acquired dementia, Varicose veins, Nausea, Tinnitus, Impaired attention and memory, Dizziness, Diabetic retinopathy, Concussion and other brain injuries, Raynaud’s disease, Stroke after-effects, Migraine, Meniere’s disease
Active ingredient
Dihydroergocriptine, Caffeine
Composition
1 tablet contains:
the active ingredients:
dihydroergocriptine a-mesylate – 4.0 mg
caffeine – 40.00 mg;
auxiliates:
Lactose monohydrate – 94.1 mg,
Microcrystalline cellulose (Avicel PH102) – 60.0 mg,
magnesium stearate – 1.5 mg,
anhydrous colloidal silicon dioxide (Aerosil 200) – 0.4 mg.
How to take, the dosage
Orally (with meals, with a little liquid) on 1/2-1 tablet 2 times a day.
Interaction
When concomitant administration of Vazobral and antihypertensive drugs, an additional decrease in blood pressure is possible.
Special Instructions
Vasobral has a vasodilator effect without affecting systemic blood pressure.
Contraindications
Increased individual sensitivity to the drug components.
Contraindication for long-term use: signs of heart valve defects detected by echocardiography performed before the drug administration.
Side effects
Frequency of occurrence of adverse events / adverse reactions (ADEs/NR) while taking the drug is presented in accordance with the following grading (classification of the World Health Organization): very common ≥10%; common ≥1% and <10%; infrequent ≥0,1% and <1%; rare ≥0,01% and <0,1%; very rare <0,01%.
Gastrointestinal disorders
Nausea (especially when taking the drug on an empty stomach), gastralgia, dyspepsia are possible, in these manifestations cancellation of the drug is not required.
Heart disorders
Very rare: tachycardia, decreased blood pressure, heart defects (including defects with blood regurgitation) and associated conditions (pericarditis, effusion into the pericardial cavity).
Nervous system disorders Rarely: dizziness, agitation, headache.
Immune system disorders Very rare: allergic reactions.
Overdose
An overdose may cause vomiting.
Pregnancy use
There are no clinical data on the use of Vazobral during pregnancy and lactation.
The use of the drug during breastfeeding may decrease lactation.
Weight | 0.016 kg |
---|---|
Shelf life | 4 years. Do not use after the expiration date. |
Conditions of storage | At 15 – 25 °C, out of the reach of children |
Manufacturer | Chiesi Pharmaceutici S.p.A., Italy |
Medication form | pills |
Brand | Chiesi Pharmaceutici S.p.A. |
Related products
Buy Vazobral, tablets, 30 pcs. with delivery to USA, UK, Europe and over 120 other countries.